Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRophylactic mEsh Reinforcement Versus Primary Closure After Emergency Midline Laparotomy (PREEMPT): A Multicenter Randomized Clinical Trial

NCT07753551 is registered in ClinicalTrials.gov with University of Rome Tor Vergata as lead sponsor.

NCT NCT07753551
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07753551 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRophylactic mEsh Reinforcement Versus Primary Closure After Emergency Midline Laparotomy (PREEMPT): A Multicenter Randomized Clinical Trial
Lead sponsor
University of Rome Tor Vergata
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
August 31, 2031
Enrollment
189 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

emergency abdominal surgery, incisional hernia after midline laparotomy